㈱TL Genomics
1 known investors
Develops a PCR-based chromosome testing technology called SinChro™ that measures cellular aging to assess natural fertility potential. Offers a fertility testing service and is developing in-vitro diagnostics to detect chromosomal abnormalities in myelodysplastic syndrome.
BiotechFemTechMedical Devices